GlassScriptPhysician profile
Robert Gillis
NPI 1730389545
$3,717.71
in general payments reported to CMS, 2019-2025
7 companies · $337 in 2025
The $337 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,000 · 2021: $287 · 2022: $214 · 2023: $243 · 2024: $638 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794 · Consulting Fee: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.24 |
| Consulting Fee | $423.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,000.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $654.39 | 2021-2025 | Tapestry |
| Hikma Pharmaceuticals USA | $423.20 | 2024 | Combogesic IV |
| Novus Surgical Consultants | $396.92 | 2023-2025 | |
| Stryker Corporation | $103.43 | 2025 | Pangea, Gamma |
| Acumed LLC | $73.65 | 2023 | Acumed, Innate Implant |
| Avita Medical Americas, LLC | $66.12 | 2025 | Recell, Cohealyx, Permeaderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gillis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.